Citation Impact
Citing Papers
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
2001
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2007 StandoutNobel
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
2004 Standout
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
2009 Standout
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
2006 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
Octreotide Versus Octreotide Plus Interferon-Alpha in Endocrine Gastroenteropancreatic Tumors: A Randomized Trial
2005
Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: Which is best?*
2003
Thyroid Function in Women after Multimodal Treatment for Breast Cancer Stage II/III: Comparison With Controls From a Population Sample
2009
Repopulation of cancer cells during therapy: an important cause of treatment failure
2005
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Oncoplastic breast surgery: A guide to good practice
2021
Genetic aberrance of sporadic MEN 2A component tumours: analysis of RET
2005
Is sentinel lymph node biopsy a viable alternative to complete axillary dissection following neoadjuvant chemotherapy in women with node-positive breast cancer at diagnosis? An updated meta-analysis involving 3,398 patients
2016
Aging, Longevity, Inflammation, and Cancer
2004
Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours
2009
Recent Insights into the Molecular Pathogenesis of Pheochromocytoma and Paraganglioma
2006 StandoutNobel
Role of Gemcitabine in Breast Cancer Management: An Update
2006
Drug penetration in solid tumours
2006 Standout
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
2009 Standout
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy
2009
A multigenic program mediating breast cancer metastasis to bone
2003 Standout
Improving Breast Cancer Surgery: A Classification and Quadrant per Quadrant Atlas for Oncoplastic Surgery
2010 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells
2003
Sepsis and septic shock
2018 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
The role of intratumoral and systemic IL-6 in breast cancer
2013
Significance of interleukin-6 (IL-6) in breast cancer (review)
2006
Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy
2018 StandoutNobel
Interleukins-6 and -11 expression in primary breast cancer and subsequent development of bone metastases
2001
Honokiol alleviated neurodegeneration by reducing oxidative stress and improving mitochondrial function in mutant SOD1 cellular and mouse models of amyotrophic lateral sclerosis
2022
A study of body image in long‐term breast cancer survivors
2010 Standout
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system
2004
Oncogenic Viruses and Breast Cancer: Mouse Mammary Tumor Virus (MMTV), Bovine Leukemia Virus (BLV), Human Papilloma Virus (HPV), and Epstein–Barr Virus (EBV)
2018
Cancer as an evolutionary and ecological process
2006 Standout
The value of immunohistochemistry for collagen iv expression in colorectal carcinomas
1991
Prospective study of the antitumor efficacy of long‐term octreotide treatment in patients with progressive metastatic gastrinoma
2002
Angiogenesis as a therapeutic target
2005 StandoutNature
Drug Resistance and the Solid Tumor Microenvironment
2007 Standout
Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
2014 Standout
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
2004 Standout
The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors
2004
Chemotherapy Is More Effective in Patients with Breast Cancer Not Expressing Steroid Hormone Receptors
2004
Levothyroxine Treatment of Subclinical Hypothyroidism, Fatal and Nonfatal Cardiovascular Events, and Mortality
2012
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
2008 Standout
The Nuclear Transcription Factor κB/bcl-2 Pathway Correlates with Pathologic Complete Response to Doxorubicin-Based Neoadjuvant Chemotherapy in Human Breast Cancer
2005
Perspectives on medicinal properties of plumbagin and its analogs
2010 Standout
Works of Manuela Roncella being referenced
Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study
2005
Primary chemotherapy in locally advanced breast cancer (LABC): effects on tumour proliferative activity, bcl-2 expression and the relationship between tumour regression and biological markers
1998
Nipple sparing mastectomy: Surgical and oncological outcomes from a national multicentric registry with 913 patients (1006 cases) over a six year period
2015
Long-Acting Depot Lanreotide in the Treatment of Patients With Advanced Neuroendocrine Tumors
2000
Sentinel Lymph Node Biopsy in Breast Cancer
2015
Expression of interleukin 6 (IL-6) correlates with oestrogen receptor in human breast carcinoma
1999
Ras oncogene and the acquisition of metastasizing properties by rectal adenocarcinoma
1989
Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study
2018
Accelerated versus standard cyclophosphamide, epirubicin and5-fluorouracil or cyclophosphamide, methotrexate and5-fluorouracil: a randomized phase III trial in locally advanced breast cancer
2003
Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery
2006
Hepatic oxygen and lactate extraction during stagnant hypoxia
1991
Human saliva as route of inter-human infection for mouse mammary tumor virus
2015